Selegiline tablets

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Teva Pharmaceutical
Approval Status: Approved January 1997
Treatment Area: Parkinson’s disease

General Information

Selegiline has been approved for the treatment of Parkinson's disease. Selegiline is a generic equivalent of Somerset’s Eldepryl tablets, a drug for the treatment of Parkinson’s disease. Other generic versions of this product have been introduced over the last several months.

Get Involved

Stroke and You

Stay Informed

Resources

Our Mission Statement

National Stroke Association’s mission is to reduce the incidence and impact of stroke by developing compelling education and programs focused on prevention, treatment, rehabilitation and support for all impacted by stroke.

Visit Our Online Store

National Stroke Association

1-800-STROKES
1-800-787-6537
9707 E. Easter Lane, Suite B
Centennial, CO 80112
info@stroke.org

Clinical Trials Resource Center